Pulmonary Cell News Volume 11.08 | Mar 3 2022

    0
    45







    2022-03-03 | PULCN 11.08


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 11.08 – 3 March, 2022
    TOP STORY

    Vaccination with SARS-CoV-2 Spike Protein Lacking Glycan Shields Elicits Enhanced Protective Responses in Animal Models

    Scientists revealed that S protein glycosylation had site-differential effects on viral infectivity and found that S protein generated by lung epithelial cells had glycoforms associated with increased infectivity.
    [Science Translational Medicine]

    Full Article
    He needed a better model system. So he invented a new organoid. Watch James Wells' webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Necroptosis Triggers Spatially Restricted Neutrophil-Mediated Vascular Damage during Lung Ischemia Reperfusion Injury

    Researchers found that TLR4 signaling in vascular endothelial cells and downstream NADPH oxidase 4 expression mediated the arrest of neutrophils, a step upstream of their extravasation.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Reciprocal Regulation of IL-33 Receptor–Mediated Inflammatory Response and Pulmonary Fibrosis by TRAF6 and USP38

    Usp38−/− mice were more susceptible to inflammatory damage and death and developed more serious pulmonary fibrosis after bleomycin treatment.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Interferon-γ Promotes Monocyte-Mediated Lung Injury during Influenza Infection

    The authors identified an interferon-γ-regulated subset of monocytes, CCR2+ monocytes, as a driver of lung damage during influenza A virus infection.
    [Cell Reports]

    Full ArticleGraphical Abstract

    STAT3 Inhibition Suppresses Adaptive Survival of ALK-Rearranged Lung Cancer Cells through Transcriptional Modulation of Apoptosis

    STAT3 inhibition effectively suppressed the adaptive survival of anaplastic lymphoma kinase (ALK)-rearranged lung cancer cells by enhancing ALK inhibition-induced apoptosis.
    [npj Precision Oncology]

    Full Article

    Cathepsin F and Fibulin-1 as Novel Diagnostic Biomarkers for Brain Metastasis of Non-Small Cell Lung Cancer

    Researchers reported a novel blood-based biomarker panel for early diagnosis, monitoring of therapeutic response, and prognostic evaluation of patients with NSCLC brain metastasis.
    [British Journal of Cancer]

    Full Article

    Deregulation of AKT–mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma

    Pharmacologic inhibition of mTOR kinase by Torin2 significantly sensitized lung squamous cell carcinoma cell lines to ionizing radiation.
    [Molecular Cancer Research]

    Full Article

    LncRNA LINC00649 Recruits TAF15 and Enhances MAPK6 Expression to Promote the Development of Lung Squamous Cell Carcinoma via Activating MAPK Signaling Pathway

    Investigators unveiled the mechanism underlying long intergenic nonprotein coding RNA 0649 (LINC00649) in lung squamous cell carcinoma (LUSC) cells. As a result, LINC00649 was discovered to be with high expression in LUSC cells.
    [Cancer Gene Therapy]

    Abstract

    Extracellular Vesicles Promotes Liver Metastasis of Lung Cancer by ALAHM Increasing Hepatocellular Secretion of HG

    The effects of ALAHM on hepatocyte paracrine HGF as well as proliferation, invasion, and migration of lung adenocarcinoma cells were observed in vitro.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    H5N1 Infection Impairs the Alveolar Epithelial Barrier through Intercellular Junction Proteins via Itch-Mediated Proteasomal Degradation

    Researchers suggested that H5N1 virus infection impaired the alveolar epithelial barrier by downregulating the expression of intercellular junction proteins at the posttranslational level.
    [Communications Biology]

    Full Article

    MiR-146a Alleviates Lung Injury Caused by RSV Infection in Young Rats by Targeting TRAF-6 and Regulating JNK/ERKMAPK Signaling Pathways

    MiR-146a alleviated lung injury caused by respiratory syncytial virus (RSV) infection in young rats by targeting TRAF-6 and regulating JNK/ERK/MAPK signaling pathways.
    [Scientific Reports]

    Full Article
    PneumaCult for primary airway epithelial cell culture at the air-liquid interface or as airway organoid.
    REVIEWS

    Integration of Liquid Biopsy and Pharmacogenomics for Precision Therapy of EGFR Mutant and Resistant Lung Cancers

    Scientists appraise current literature, opportunities, and challenges associated with liquid biopsy and pharmacogenomic testing as precision therapy tools in the management of epidermal growth factor receptor (EGFR) mutant and resistant lung cancers.
    [Molecular Cancer]

    Full Article

    Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia

    The authors take stock of the relationship between epidermal growth factor receptor (EGFR) mutations and PD-1 and its ligand receptor 1 expression and summarize the important clinical studies on immunotherapy-inhibitor-based treatment in patients with EGFR-tyrosine kinase inhibitor-resistant NSCLC.
    [Future Oncology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Genprex Announces First Patient Dosed in Phase I/II Acclaim-1 Clinical Trial of REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer

    Genprex, Inc. announced that the first patient was dosed in the Acclaim-1 clinical trial, an open-label, multi-center Phase I/II clinical trial evaluating REQORSA™ Immunogene Therapy, in combination with Tagrisso® (osimertinib) in patients with late-stage NSCLC.
    [Genprex, Inc.]

    Press Release

    AnHeart Therapeutics and Innovent Biologics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1 Fusion-Positive Non-Small Cell Lung Cancer

    AnHeart Therapeutics together with Innovent Biologics, Inc. jointly announced that the Center for Drug Evaluation of China’s Nation Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation to taletrectinib.
    [AnHeart Therapeutics]

    Press Release
    FEATURED EVENT

    AACR Annual Meeting 2022

    April 8 – 13, 2022
    New Orleans, Louisiana, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Epithelial/Stem Cell Activity

    King’s College London – London, United Kingdom

    Postdoctoral Fellow – Functional Genomics of Lung Cancer

    University of California San Francisco – San Francisco, California, United States

    Postdoctoral Research Scientist – Immunology

    Babraham Institute – Babraham, Cambridgeshire, United Kingdom

    Postdoctoral Positions – Translational 3D Pathology

    University of Washington – Seattle, Washington, United States

    Postdoctoral Research Fellow – Tumor Metabolism

    Wayne State University School of Medicine – Detroit, Michigan, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter